Novartis has signed a collaboration agreement and an option to acquire Cellerys. The Zurich-based startup is researching an innovative therapy to combat multiple sclerosis (MS).
Dermavant Sciences announced that the company has entered into a USD 160m revenue interest purchase and sale agreement for its investigational product tapinarof with three participants.
Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m.
ubitec AG, a developer of innovative software solutions for digitization, was acquired by UMB Solutions AG, a leading Swiss IT services provider.
DomoSafety SA, a leading company in the digital health segment, announced the successful closing of its Series B financing round.
Faveeo SA, a Swiss start-up, announced the successful closing of its Series B financing round.
HAYA Therapeutics SA announced the successful closing of its CHF 18m seed round.
Oculis S.A., a late-stage biopharmaceutical company, focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, has closed an oversubscribed USD 57m Series C financing round.
RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company, acquires Applied Pharma Research S.A., a privately held Swiss pharmaceutical company.
The previous owners of Mestex AG, a Swiss biotech company developing, sold their shares and stock options to the pharmaceutical company Grünenthal